Nanomedicine News

RSS

Project on Bioinspired Silicate Nanocomposites for Cartilage Tissue Engineering Receives Sigma Xi GIAR

James Carrow, graduate student in the Department of Biomedical Engineering at Texas A&M University, has been named recipient of a Sigma Xi Grant-in-Aid of Research (GIAR).

23 Apr 2015

Tiny Sensors with Nanoparticles to Detect Insecticides, Cancers

A Case Western Reserve University researcher has won a $500,000 National Science Foundation grant to create tiny sensors capable of detecting insecticides in Lake Erie or determining subtypes of human cancers.

23 Apr 2015

Nanoparticle-Based Skin Ointment May Help Heal Painful Ulcers in Diabetic Patients

A new high-tech but simple ointment applied to the skin may one day help diabetic patients heal stubborn and painful ulcers on their feet, Northwestern University researchers report.

23 Apr 2015

Dopamine Packaged in Biodegradable Nanoparticles Reverses Parkinson's-Like Symptoms

As baby boomers age, the number of people diagnosed with Parkinson's disease is expected to increase. Patients who develop this disease usually start experiencing symptoms around age 60 or older. Currently, there's no cure, but scientists are reporting a novel approach that reversed Parkinson's-like symptoms in rats. Their results, published in the journal ACS Nano, could one day lead to a new therapy for human patients.

From American Chemical Society 23 Apr 2015

Blend Therapeutics Announces Presentation of Preclinical Data on Lead Pentarin Program, BTP-277

Blend Therapeutics, Inc., a biopharmaceutical company discovering and developing two distinct classes of targeted anti-cancer medicines to advance the treatment of patients with solid tumor cancers, presented preclinical data today on its lead Pentarin™ program, BTP-277, showing specific and potent targeting of tumor cells expressing the somatostatin receptor, which is known to be over expressed in small cell lung cancer (SCLC) and neuroendocrine cancer tumor cells.

22 Apr 2015

Oasmia's Paclical Nanoparticle Cancer Drug with Paclitaxel Receives Russian Health Ministry Market Authorization

Oasmia Pharmaceutical AB ("Oasmia") announced today that its lead cancer product Paclical received market authorization in the Russian Federation by the Russian Ministry of Health. Paclical is the first water-soluble cancer drug with paclitaxel to receive a market authorization. Paclical is planned for launch in the second half of 2015.

21 Apr 2015

Anti-Herpes Nanoviricides Reduce Extent of Disease and Mortality of HSV-1 Infected Animals

NanoViricides, Inc., (the "Company"), a nanomedicine company developing anti-viral drugs, reports dramatic improvement in clinical symptoms associated with herpes simplex virus infection in the recently completed studies in mice. The studies were performed in the laboratory of Dr. Ken S. Rosenthal at Northeast Ohio Medical University where Dr. Rosenthal is now Professor Emeritus. He is a leading researcher in herpes virus anti-viral agents and vaccines.

From NanoViricides, Inc 21 Apr 2015

Easy, Effective Method to Fasten Proteins to Nanoparticles for Cancer Treatment

Fastening protein-based medical treatments to nanoparticles isn't easy.

21 Apr 2015

Lab-on-a-Chip Device for Rapid Diagnosis of Cryptosporidium Infections

For a healthy individual, an infection of Cryptosporidium parvum may mean nothing more than a few days of bad diarrhea. For someone with a compromised immune system, it can mean death, following an excruciating, protracted bout of watery diarrhea.

16 Apr 2015

InMed Receives Mitacs Grant to Further Develop Nanoparticle-Based Drug Delivery System for Glaucoma

InMed Pharmaceuticals Inc., a clinical stage biopharmaceutical company that specializes in developing safer, more effective cannabinoid-based therapies, today announced that it has been awarded a grant to further develop the Company's proprietary nanoparticle-based delivery system for their leading drug candidate CTI-085 for glaucoma.

16 Apr 2015

Nanomedicine News

Project on Bioinspired Silicate Nanocomposites for Cartilage Tissue Engineering Receives Sigma Xi GIAR

Tiny Sensors with Nanoparticles to Detect Insecticides, Cancers

Nanoparticle-Based Skin Ointment May Help Heal Painful Ulcers in Diabetic Patients

Dopamine Packaged in Biodegradable Nanoparticles Reverses Parkinson's-Like Symptoms

Blend Therapeutics Announces Presentation of Preclinical Data on Lead Pentarin Program, BTP-277

Oasmia's Paclical Nanoparticle Cancer Drug with Paclitaxel Receives Russian Health Ministry Market Authorization

Anti-Herpes Nanoviricides Reduce Extent of Disease and Mortality of HSV-1 Infected Animals

Easy, Effective Method to Fasten Proteins to Nanoparticles for Cancer Treatment

Lab-on-a-Chip Device for Rapid Diagnosis of Cryptosporidium Infections

InMed Receives Mitacs Grant to Further Develop Nanoparticle-Based Drug Delivery System for Glaucoma

Laser-Induced Graphene for Printable and Biomedical Applications

Mapping Nanomaterial Atomic Structure Without Beam Damage

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Sustainable Hydrogen and Chemical Synthesis via Novel Electrocatalyst

Co-Solvent-Driven Laser Assembly of Gold Nanorods

Breaking Barriers in Thin-Film Deposition with ATLANT 3D’s DALP Technology

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

Sponsored Content

Unlocking Material Behavior at the Microscale Using Nanoindentation

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination